Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan/Docetaxel vs Docetaxel in Advanced NSCLC
NCT00065182Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2003
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of topotecan in non-small cell lung cancer (NSCLC), sponsored by GSK. Started Aug 2003; status: completed.
02
Drugs
topotecan
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00065182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065182.